secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytek Biosciences, Inc. (CTKB)
CIK:        0001831915
Form:       8-K
Filed at:   2022-06-06T23:59:59+00:00
Accession:  0001193125-22-168332
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cytek Biosciences reports 2022 annual meeting voting results; Class I directors elected and auditor ratified
--------------------------------------------------------------------------------

- Deborah Neff and Don Hardison elected as Class I directors with ~88.7M and ~88.7M votes for, respectively.
- Ratification of Deloitte & Touche as auditor for FY2022 approved with 115.4M votes for, 5,450 against.
- Approximately 86% of outstanding shares (116M out of 134.2M) represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831915/000119312522168332/0001193125-22-168332-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831915/000119312522168332/d367623d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-168332

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer